Results: 1-25 | 26-50 | 51-68
Results: 1-25/68

Authors: Nadal, E Cervantes, F Rosinol, L Talarn, C Montserrat, E
Citation: E. Nadal et al., Hypercalcemia as the presenting feature of T-cell lymphoid blast crisis ofph-positive chronic myeloid leukemia, LEUK LYMPH, 41(1-2), 2001, pp. 203-206

Authors: Hernandez-Boluda, JC Cervantes, F Alvarez, A Costa, D Montserrat, E
Citation: Jc. Hernandez-boluda et al., Single-agent therapy with oral mercaptopurine for nonlymphoid blast crisisof chronic myeloid leukemia, ANN HEMATOL, 80(9), 2001, pp. 516-520

Authors: Ferrer, A Lopez-Guillermo, A Montoto, S Estrach, T Colomo, L Montserrat, E
Citation: A. Ferrer et al., Successful treatment of isolated cutaneous relapse of follicular lymphoma with rituximab, ANN HEMATOL, 80(8), 2001, pp. 479-481

Authors: Montserrat, E
Citation: E. Montserrat, Prognostic factors in aggressive lymphoma: The contribution of novel biological markers, ANN HEMATOL, 80, 2001, pp. B42-B44

Authors: Martinez-Noguera, A Montserrat, E Torrubia, S Monill, JM Estrada, P
Citation: A. Martinez-noguera et al., Ultrasound of the pancreas: update and controversies, EUR RADIOL, 11(9), 2001, pp. 1594-1606

Authors: Cervantes, F Barosi, G Hernandez-Boluda, JC Marchetti, M Montserrat, E
Citation: F. Cervantes et al., Myelofibrosis with myeloid metaplasia in adult individuals 30 years old oryounger: presenting features, evolution and survival, EUR J HAEMA, 66(5), 2001, pp. 324-327

Authors: Esteve, J Villamor, N Colomer, D Cervantes, F Campo, E Carreras, E Montserrat, E
Citation: J. Esteve et al., Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease status, LEUKEMIA, 15(3), 2001, pp. 445-451

Authors: Sanz-Vaque, L Colomer, D Bosch, F Lopez-Guillermo, A Dreyling, MH Ott, G Montserrat, E Campo, E
Citation: L. Sanz-vaque et al., Microsatellite instability analysis in typical and progressed mantle cell lymphoma and B-cell chronic lymphocytic leukemia, HAEMATOLOG, 86(2), 2001, pp. 181-186

Authors: Cervantes, F Sureda, A Hernandez-Boluda, JC Martino, R Brunet, S Borrego, D Antich, JL Montserrat, E
Citation: F. Cervantes et al., Interferon alpha plus intermittent oral Ara-C ocfosfate (YNK-01) in chronic myeloid leukemia primarily resistant or with minimal cytogenetic responseto interferon, HAEMATOLOG, 86(12), 2001, pp. 1281-1286

Authors: Urbano-Ispizua, A Brunet, S Solano, C Moraleda, JM Rovira, M Zuazu, J de la Rubia, J Bargay, J Caballero, D Diez-Martin, JL Ojeda, E de Oteiza, JP Ferra, C Espigado, I Alegre, A de la Serna, J Torres, P Riu, C Odriozola, J Rozman, C Sierra, J Garcia-Conde, J Montserrat, E
Citation: A. Urbano-ispizua et al., Allogeneic transplantation of CD34(+)-selected cells from peripheral bloodin patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantation, BONE MAR TR, 28(4), 2001, pp. 349-354

Authors: Martinez, C Carreras, E Rovira, M Urbano-Ispizua, A Esteve, J Fernandez-Aviles, F Perales, M Rives, S Gomez, M Montserrat, E
Citation: C. Martinez et al., Allogenic stem cell transplantation as salvage therapy for patients relapsing after autologous transplantation: experience from a single institution, LEUK RES, 25(5), 2001, pp. 379-384

Authors: Blade, J Esteve, J Rosinol, L Perales, M Montoto, S Tuset, M Montserrat, E
Citation: J. Blade et al., Thalidomide in refractory and relapsing multiple myeloma, SEMIN ONCOL, 28(6), 2001, pp. 588-592

Authors: Villela, L Lopez-Guillermo, A Montoto, S Rives, S Bosch, F Perales, M Ferrer, A Esteve, J Colomo, L Campo, E Montserrat, E
Citation: L. Villela et al., Prognostic features and outcome in patients with diffuse large B-cell lymphoma who do not achieve a complete response to first-line regimens, CANCER, 91(8), 2001, pp. 1557-1562

Authors: Rovira, M Carreras, E Blade, J Graus, F Valls, J Fernandez-Aviles, F Montserrat, E
Citation: M. Rovira et al., Dramatic improvement of POEMS syndrome following autologous haematopoieticcell transplantation, BR J HAEM, 115(2), 2001, pp. 373-375

Authors: Blade, J Perales, M Rosinol, L Tuset, M Montoto, S Esteve, O Cobo, F Villela, L Rafel, M Nomdedeu, B Montserrat, E
Citation: J. Blade et al., Thalidomide in multiple myeloma: lack of response of soft-tissue plasmacytomas, BR J HAEM, 113(2), 2001, pp. 422-424

Authors: Bellosillo, B Villamor, N Lopez-Guillermo, A Marce, S Esteve, J Campo, E Colomer, D Montserrat, E
Citation: B. Bellosillo et al., Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of reactive oxygen species, BLOOD, 98(9), 2001, pp. 2771-2777

Authors: Urbano-Ispizua, A Carreras, E Marin, P Rovira, M Martinez, C Fernandez-Aviles, F Xicoy, B Hernandez-Boluda, JC Montserrat, E
Citation: A. Urbano-ispizua et al., Allogeneic transplantation of CD34(+) selected cells from peripheral bloodfrom human leukocyte antigen-identical siblings: detrimental effect of a high number of donor CD34(+) cells?, BLOOD, 98(8), 2001, pp. 2352-2357

Authors: Urbano-Ispizua, A Rozman, C Pimentel, P Solano, C de la Rubia, J Brunet, S Perez-Oteiza, J Ferra, C Zuazu, J Caballero, D Carvalhais, A Diez, JL Espigado, I Martinez, C Campilho, F Sanz, MA Sierra, J Garcia-Conde, J Montserrat, E
Citation: A. Urbano-ispizua et al., The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblings, BLOOD, 97(2), 2001, pp. 383-387

Authors: Villamor, N Costa, D Aymerich, M Esteve, J Carrio, A Rozman, M Aguilar, JL Falini, B Montserrat, E Campo, E Colomer, D
Citation: N. Villamor et al., Rapid diagnosis of acute promyelocytic leukemia by analyzing the immunocytochemical pattern of the PML protein with the monoclonal antibody PG-M3, AM J CLIN P, 114(5), 2000, pp. 786-792

Authors: Hernandez-Boluda, JC Cervantes, F Costa, D Carrio, A Montserrat, E
Citation: Jc. Hernandez-boluda et al., Blast crisis of Ph-positive chronic myeloid leukemia with isochromosome 17q: Report of 12 cases and review of the literature, LEUK LYMPH, 38(1-2), 2000, pp. 83-90

Authors: Martinez, C Urbano-Ispizua, A Rovira, M Carreras, E Rozman, C Montserrat, E
Citation: C. Martinez et al., Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation, LEUK LYMPH, 37(5-6), 2000, pp. 535-542

Authors: Hernandez-Boluda, JC Cervantes, F Alvarez, A Lopez-Guillermo, A Montserrat, E
Citation: Jc. Hernandez-boluda et al., Non-Hodgkin's lymphoma following untreated essential thrombocythemia, LEUK LYMPH, 36(3-4), 2000, pp. 421-423

Authors: Cid, J Revilla, M Cervera, A Cervantes, F Munoz, E Ferrer, I Montserrat, E
Citation: J. Cid et al., Progressive multifocal leukoencephalopathy following oral fludarabine treatment of chronic lymphocytic leukemia, ANN HEMATOL, 79(7), 2000, pp. 392-395

Authors: Cervantes, F Hernandez-Boluda, JC Villamor, N Serra, A Montserrat, E
Citation: F. Cervantes et al., Assessment of peripheral blood lymphocyte subsets in idiopathic myelofibrosis, EUR J HAEMA, 65(2), 2000, pp. 104-108

Authors: Cervantes, F Hernandez-Boluda, JC Alvarez, A Nadal, E Montserrat, E
Citation: F. Cervantes et al., Danazol treatment of idiopathic myelofibrosis with severe anemia, HAEMATOLOG, 85(6), 2000, pp. 595-599
Risultati: 1-25 | 26-50 | 51-68